tldrdaily.news logo

Apnimed's Oral Pill Shows Promise in Sleep Apnea Treatment

1 min read
Source: The New York Times
Apnimed's Oral Pill Shows Promise in Sleep Apnea Treatment
Photo: The New York Times
TL;DR Summary

A new oral medication called AD109 shows promise in treating sleep apnea, potentially offering a more comfortable alternative to CPAP machines, with positive Phase 3 trial results indicating it could be approved by the FDA in 2026, though full data on side effects and efficacy in chronic conditions are pending.

Topics:business#ad109#clinical-trials#cpap-alternative#health#sleep-apnea#sleep-treatment
Share this article
  1. A Pill for Sleep Apnea Could Be on the Horizon  The New York Times
  2. Apnimed announces positive results from second clinical trial of sleep apnea medication  American Academy of Sleep Medicine | AASM
  3. Apnimed firms up filing plans for oral sleep apnoea drug after second pivotal study win  FirstWord Pharma
  4. Apnimed's sleep apnea asset goes 2 for 2 in phase 3, solidifying star potential  Fierce Biotech
  5. Positive Topline Results From Phase 3 Trial of AD109, First Oral Pill for Obstructive Sleep Apnea  Psychiatric Times

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

5 min

vs 5 min read

Condensed

95%

954 → 50 words

Want the full story? Read the original article

Read on The New York Times